We are live on ! Find out more
BFO

Boston Family Office Portfolio holdings

AUM $1.65B
1-Year Est. Return 18.1%
This Fund
S&P 500
This Quarter Est. Return
+8.66%
1 Year Est. Return
+18.1%
3 Year Est. Return
+53.4%
5 Year Est. Return
+63.18%
10 Year Est. Return
+288.04%
AUM
$1.05B
AUM Growth
+$87.6M
Cap. Flow
+$11M
Cap. Flow %
1.05%
Top 10 Hldgs %
25.51%
Holding
257
New
6
Increased
69
Reduced
106
Closed
4

Top Buys

Rank Stock Value
1
MRSH
Marsh
MRSH
+$16.4M
2
ATR icon
AptarGroup
ATR
+$2.92M
3
CVX icon
Chevron
CVX
+$970K
4
WM icon
Waste Management
WM
+$911K
5
MSFT icon
Microsoft
MSFT
+$677K

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$1.49M
2
AAPL icon
Apple
AAPL
+$1.01M
3
PM icon
Philip Morris
PM
+$958K
4
CELG
Celgene Corp
CELG
+$924K
5
XOM icon
ExxonMobil
XOM
+$883K

Sector Composition

Rank Sector Weight
1 Technology 18.67%
2 Healthcare 16.26%
3 Miscellaneous 13.33%
4 Financials 11.97%
5 Industrials 9.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRCL
76
DELISTED
Stericycle Inc
SRCL
$3.73M 0.36%
58,495
D icon
77
Dominion Energy
D
$56.3B
$3.72M 0.35%
44,941
+205
+0.5% +$16.8K
PM icon
78
Philip Morris
PM
$303B
$3.69M 0.35%
43,365
-11,624
-21% -$958K
RTN
79
DELISTED
Raytheon Company
RTN
$3.59M 0.34%
16,342
-1,628
-9% -$344K
NSC icon
80
Norfolk Southern
NSC
$72.1B
$3.52M 0.33%
18,123
GLNG icon
81
Golar LNG
GLNG
$5.15B
$3.46M 0.33%
243,015
+40,278
+20% +$546K
VEU icon
82
Vanguard FTSE All-World ex-US ETF
VEU
$69.1B
$3.42M 0.33%
63,701
-1,107
-2% -$57.5K
GOOGL icon
83
Alphabet (Google) Class A
GOOGL
$4.22T
$3.34M 0.32%
49,840
+1,260
+3% +$81.3K
PH icon
84
Parker-Hannifin
PH
$117B
$3.28M 0.31%
15,924
-47
-0.3% -$9.11K
IFF icon
85
International Flavors & Fragrances
IFF
$21.5B
$3.17M 0.3%
24,607
-5,679
-19% -$725K
EOG icon
86
EOG Resources
EOG
$80.5B
$3.12M 0.3%
37,291
-8,319
-18% -$609K
WY icon
87
Weyerhaeuser
WY
$16B
$3.1M 0.3%
102,746
-705
-0.7% -$20.5K
BMY icon
88
Bristol-Myers Squibb
BMY
$130B
$3.05M 0.29%
47,579
+7,466
+19% +$428K
VIG icon
89
Vanguard Dividend Appreciation ETF
VIG
$111B
$2.85M 0.27%
22,882
+600
+3% +$72.6K
NVO
90
Novo Nordisk
NVO
$188B
$2.72M 0.26%
93,934
ORCL icon
91
Oracle
ORCL
$404B
$2.59M 0.25%
48,948
-1,968
-4% -$108K
MDLZ icon
92
Mondelez International
MDLZ
$79.3B
$2.58M 0.25%
46,800
+1,179
+3% +$63.1K
AMGN icon
93
Amgen
AMGN
$203B
$2.56M 0.24%
10,625
-93
-0.9% -$20.5K
T icon
94
AT&T
T
$184B
$2.56M 0.24%
86,643
+772
+0.9% +$22.3K
MO icon
95
Altria Group
MO
$117B
$2.54M 0.24%
50,785
-8,741
-15% -$412K
IJH icon
96
iShares Core S&P Mid-Cap ETF
IJH
$122B
$2.52M 0.24%
61,095
+305
+0.5% +$12.1K
THO icon
97
Thor Industries
THO
$3.71B
$2.44M 0.23%
32,892
+325
+1% +$21K
SEDG icon
98
SolarEdge
SEDG
$2.18B
$2.44M 0.23%
25,670
CL icon
99
Colgate-Palmolive
CL
$69.5B
$2.32M 0.22%
33,661
ITW icon
100
Illinois Tool Works
ITW
$76.4B
$2.3M 0.22%
12,782
-50
-0.4% -$8.47K

Similar funds

Boston Family Office's Q4 2019 Portfolio in Review

As of Q4 2019, Boston Family Office held 257 positions worth $1.05B, up 9.1% from $964M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Trading was light in Q4 2019: portfolio turnover was 3.9%. Boston Family Office opened 6 new positions and exited 4, leaving the 257-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Miscellaneous.

  • Boston Family Office's largest Q4 2019 buy was Constellation Brands: 1,475 shares worth $280K.
  • Boston Family Office added most to Marsh in Q4 2019, an estimated $16.4M increase.
  • Boston Family Office's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $1.49M.
  • Boston Family Office fully exited Celgene Corp in Q4 2019, selling an estimated $924K.
  • Boston Family Office's ten largest holdings make up 26% of its $1.05B portfolio in Q4 2019.
  • Boston Family Office opened 6 new positions and closed 4 in Q4 2019.
  • Boston Family Office's portfolio value rose 9.1% quarter-over-quarter to $1.05B.

Based on Boston Family Office's 13F filing for Q4 2019, filed 5 Feb 2020.